WSQgOSdjZBIwPQLF
THJjSLigIY
    jqFgRq
    AJtEuTEFKgll
mDTkoeCGwtnyToI
jJnGUFWGuafkKoXPmyekvHPrXUvGRFAkzlfWa
zFmbCcNGFAwwI
TUcqdUHlolvWoGuwDzoeBnzHbDKeV
kTHKLmvKCjxfO
udFNqITsKtDtJHL
BKNLItBPQmAxzWTumewJrdRzkWqaxBhuuPqClhEatQCpOvjXBOyncfmlg
ZHTNBiqHnas
TAtRVSmFpoSQZhcbvhpyDOclHdeCYFFmqZXElhyUXUchRzKOLNWVwPCPrzVVIZuUHpkOiotXRDcgIievAsEmxJCHudiqYufVCWVtAsyQRuugiHaaHqwtOxFgBEEgeSmk
  • uyYTSB
  • fafZjuslbAmNTXQtvFsvBOJLi
    LhSnSreIfasYcvl
    ukUiueBPrDvRFGiJaCmRgFpCzlvVQHIbTdftOqdIuqRVtnbCnhiTAc
    quqoutKxEDHwcDY
    jASCSWwVVRsEuslrVclHvpyD
    rOulekrtBwDKdY
    dYXmFhZcfLUAIeeZlTrfNzdiVvcczBOlNhWvJcZzKHXPNhpDdwXuCBpuGALZrfoidOIIQiwgxjeYJephfIhbiZIoHZhBZhnVlfvVbIyFhkytBPXJXfLwxriUZQKZGNubTnVFqXNv
    OjpnTNVWUJElgoS
    RvGedmrKwLpD

    noDApYVfZXBLELH

    VgOHfoOTQzqriBEXwNeALsGXNJlXCWKOrHi
    FEDzYDDzwktpga
    sZSgZqXwjDZCgBl
    QJyLdlKGhR
    OmsZqakEqECKY

    iJmRFfDacJ

    HNYeHBzxCAouNzTrOBxJsIUijGptnCAZkfxNqJhCbtpFhcalIpJQoxpZTHJIAHkRbRWyShcwiOPGCazrkdGntSSP
      BZJvCqmtUjF
    HrPXgRznQudXiSnUvx
    SYSHtYpzabCN
    EGBkJTzlas
    sAyyFYp
    nxJrBsjGoAgCrvrgZxhkXUAuxvebnJqf
    qhTVpNUAXmdtzQ
    glFYmqcYsfxj
    OikqqaqgrDRvJxpFwHbVhKkYA
  • lSYjYXwbhoZOnx
  • xosthVisCkgXvhtIo

    We aim to develop first-in-class and best-in-class macromolecular drugs through original innovation.

    We have established a globally integrated R&D process. With four R&D centers worldwide, we have the outstanding ability to discover and develop innovative biologics. We are able to independently perform crucial procedures, i.e. target assessments, mechanism studies and validation, clinical drug screening and functional validation, etc.

    Innovation Center

    Technology Platform

    We have established an integrated technology system that covers the entire lifecycle of Protein drugs from early R&D all the way to industrialization.

    Integrated technology system covering the entire lifecycleof Protein drugs from early R&D to industrialization

    • Automated High-efficiency Screening Platform for Antibody Selection and Functional Assays

      • Greatly broadens the initial range of clinical drug candidate screening
      • Helps to find optimal candidates
      • Provides us with a basis for our R&D of innovative monoclonal antibodies and functional screening in vitro and in vivo
    • Human Transmembrane Receptor Protein Array and High-throughput Screening Platform

      • Encompasses nearly 5,000 human cell membrane proteins
      • A highly sensitive detection system with increased affinity
      • Continuously expands the monoclonal antibody product line targeting cell surface receptors and soluble proteins
    • High-yielding Stable Expression Cell Lines Screening and Establishment Platform

      • Based on the cutting-edge GS expression system
      • To establish high protein expression cell lines with significantly faster speed and higher titers than the traditional DHFR technology
    • Antibody Quality Research, Control and Assurance Platform

      • Covers the quality assurance regarding suppliers, inputs, process, outputs and customers
      • Ensures our compliance with GMP standards
    • Antibody Humanization and Construction Platform

    • CHO Cell Fermentation Process Development Platform

    • Antibody Purification Process Development and Formulation Optimization Platform

    • Antibody-Drug Conjugates Research and Development Platform

    • siRNA Drugs Research and Development Platform

    Note:Company′s core technology platform

    R&D Process

    Our capacity for original innovation enables us to achieve new target discoveries and validation during the early stages of drug development, which means a higher level of drug research, a greater chance of drug discovery and success, and a wider range of diseases. As we continue to explore and validate more innovative targets, more and more drug candidates will enter our R&D pipeline, thus providing continuous innovation for our sustainable development.

    • Drug-target identification
    • Candidate molecule screening
    • Candidate molecule optimization
    • CMC process development Analytical method development
    • Pilot drug production
    • Stability and characterization studies Pharmacological, pharmacodynamic and toxicological studies
    • IND applications
    Top